Finally, the dust created by the #immunotherapy revolution has started to settle and it looks like humanity will exit the war on cancer with the upper hand
Recently, the Nucleai team hosted a meetup with some of the greatest minds and innovators in the cancer therapy space. Not only was the event exciting and engaging, but it also placed the breakthrough developments we’re working on with partners from some of Israel’s leading medical centers, research institutes, and Biomed facilities, front, and center. […]
Spatial analysis – the missing piece in biology research
In 2007, Nature journal named next-generation sequencing as “Method of the Year.” Since then, DNA and RNA sequencing have respectively become standard, feasible methods for evaluating DNA mutations, copy number variations, and gene expression of tumors. As a result, the characterization of normal and diseased tissues at the molecular level has produced large biological catalogues and atlases that have been utilized for biological research, target discovery, and the development of novel drugs.
The new generation of biomarkers – tumor-microenvironment spatial analysis – Taking the AI image analysis technology and going beyond PD-L1 staining.
At Nucleai, we have been building the largest spatial biology atlas with a clear understanding that an algorithm is only as powerful as the data behind it. With that in mind, we are developing models for the next generation of precision medicine and novel biomarker discovery.